Color Study (High-Risk Breast Lesions) - Clinical Trial
Email to Participate
jennifer.plichta@duke.edu
What is the Purpose of this Study?
Treatment
If you choose to join this study, you will:
- Give a saliva sample
- Have a genetic test using the Color Genomics 30 gene hereditary panel test
What is the Condition Being Studied?
Objective
Genetic Testing
Who Can Participate in the Study?
Key Eligibility
Women diagnosed with high-risk breast lesions including:
- Lobular carcinoma in situ (LCIS)
- Atypical ductal hyperplasia (ADH)
- Atypical lobular hyperplasia (ALH)
- Flat epithelial atypia (FEA)
- Columnar cell hyperplasia (CCH)
Age Group
Adults
What is Involved?
Description
We are doing this study to screen women diagnosed with high-risk breast lesions for genetic mutations that may be linked to a future risk of cancer.
Study Details
Full Title
Genetic testing for women with high-risk breast lesions
Principal Investigator
Surgical Oncologist
Protocol Number
IRB:
PRO00089223
NCT:
NCT00000000
Phase
Phase
N/A
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate